Robert S. King
Net Worth
Last updated:
What is Robert S. King net worth?
The estimated net worth of Dr. Robert S. King is at least $5,486,352 as of 2 Sep 2022. He owns shares worth $1,132,691 as insider, has earned $1,016,401 from insider trading and has received compensation worth at least $3,337,260 in Alector, Inc..
What is the salary of Robert S. King?
Dr. Robert S. King salary is $556,210 per year as Chief Devel. Officer in Alector, Inc..
How old is Robert S. King?
Dr. Robert S. King is 62 years old, born in 1963.
What stocks does Robert S. King currently own?
As insider, Dr. Robert S. King owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Alector, Inc. (ALEC) | Chief Devel. Officer | 529,295 | $2.14 | $1,132,691 |
What does Alector, Inc. do?
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.
Robert S. King insider trading
Alector, Inc.
Dr. Robert S. King has made 11 insider trades between 2019-2022, according to the Form 4 filled with the SEC. Most recently he sold 176 units of ALEC stock worth $1,869 on 2 Sep 2022.
The largest trade he's ever made was exercising 60,000 units of ALEC stock on 2 Jul 2021. As of 2 Sep 2022 he still owns at least 529,295 units of ALEC stock.
Alector key executives
Alector, Inc. executives and other stock owners filed with the SEC:
- Dr. Arnon Rosenthal (69) Co-Founder, Chief Executive Officer & Director
- Dr. Robert Paul M.D., Ph.D. (57) Advisor
- Dr. Robert S. King (62) Chief Devel. Officer
- Dr. Tillman Ulf Gerngross Ph.D. (61) Co-Founder & Chairman
- Mr. Calvin Yu (49) Vice President of Fin.